Pfizer-BioNTech Kid's COVID Vaccine
COVID Kids' Vaccine Moves Forward
100% Effective in Initial Data From Trials
Germany based BioNTech and Pfizer announced today that their COVID-19 vaccine is 100% effective in teens, according to their initial data from ongoing trials in children from 12 to 15 years old. The companies added kids tolerate the vaccine very well. Their vaccine has already been approved for emergency use in young people 16 year old plus and adults. The companies, based on their new data, say that they believe it is safe and effective for kids 12 to 15 years old to receive the two shot vaccine. Their data is being forwarded to the FDA for its review and possible approval for use in young teens to protect them from COVID. The companies hope to start vaccinating kids before the start of the new school year in fall of 2021.
Testing Ongoing For Kids of All Ages
The Pfizer-BioNTech vaccine has been shot into the arms of hundreds of millions of adults around the world. The two companies are now conducting trials for use on three separate very young age groups: children 6 months to 2 years, 2 to 5 years and 5 to 11 years to see if it can be rolled out for their use with safety and effectiveness. In the Phase 3 trials on kids 12 to 15 years old, the two shot regimen triggered a very strong and effective antibody response to stop COVID in the recipient.
For a comprehensive look at new German innovations like the BioNTech COVID vaccine, go to https://read.amazon.com/kp/embed?asin=B091FQ4774&preview=newtab&linkCode=kpe&ref_=cm_sw_r_kb_dp_AY7GNY5ZZAWEEQABZZRX
Comments
Post a Comment